⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 1 hour ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 1 hour ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT May 26, 2026

Ursofalk 250 mg - Kapseln 250 mg (Hartkapsel)

📷 EU Safety Watch placeholder
Ursofalk 250 mg - Kapseln 250 mg (Hartkapsel)
📷 EU Safety Watch placeholder
Ursofalk 250 mg capsules are subject to a parallel export ban due to increased demand.
⚠️
Shortage ongoing
URSODEOXYCHOLSÄURE is currently in short supply in AT.
📈 Timeline
1 days active so far
May 27, 2026 May 27, 2026
Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.

What is this? This is a medicine called Ursofalk. It comes in 250 mg capsules. It is used to treat liver and gallbladder problems.

What's happening? There is less of this medicine available right now. The shortage may last until August.

Does this affect me? If you take this medicine, you might have trouble getting it. Check with your pharmacist.

What should I do? Do not stop taking it without asking your pharmacist or doctor. They can help you find a solution.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
URSODEOXYCHOLSÄURE
Agency-published detail

🚫 Parallel export ban active · ATC: A05AA02 · Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: Dr. Falk Pharma GmbH, Leinenweberstraße 5, 79108 Freiburg Im Breisgau, Federal Republic of Germany · Affected packs: 50 Stück Schachtel, Blisterpackung [eingeschränkt verfügbar, since 2026-05-21, resupply 2026-08-05]

First published
May 26, 2026
Last refreshed by us
13 hours ago
Severity (as classified)
Medium
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

Medium AT resolved 8 months ago

Ursogrix 250 mg Hartkapseln 250 mg (Hartkapsel)

Parallel export ban in effect for Ursogrix 250 mg hard capsules.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Ursofalk 250 mg - Kapseln 250 mg (Hartkapsel). Ursofalk 250 mg capsules are subject to a parallel export ban due to increased demand.
▸ When was this alert issued?
This alert was issued on May 26, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.